Beam Therapeutics to Present at Jefferies 2020 Virtual Healthcare Conference

CAMBRIDGE, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will present at the Jefferies 2020 Virtual Healthcare Conference on Thursday, June 4, 2020 at 9:30 a.m. ET. The conference is being held virtually from June 2-4, 2020.

The live webcast will be available in the investor section of the company's website at www.beamtx.com. The webcast will be archived for 60 days following the presentation.

About Beam Therapeutics

Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company developing precision genetic medicines through the use of base editing. Beam’s proprietary base editors create precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. For more information, visit www.beamtx.com.

Contacts:

Investors:Alicia Davis, THRUST Strategic Communications[email protected]

Media:Dan Budwick1AB[email protected]

You May Also Be Interested In

• Austin Air Systems Launches Parent Teacher Toolkit to Help Schools Extend the Life of Classroom HEPA Air Purifiers and Support Cleaner Indoor Air
• Selling A Business in New York City: Valuation, Preparation, Best Practices (2026 Guide Released)
• New Crypto Presale: Pepeto Races Past $10.59M And Ethereum Price Prediction Stretches to $10,000